Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",49706,300,1.06 [0.91-1.24],0.4265916574663636
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",51506,398,1.06 [0.93-1.20],0.4206048593822918
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",50974,2775,1.04 [0.99-1.09],0.1427694191968406
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,Candidiasis,51545,860,1.00 [0.91-1.09],0.941299443750372
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,49988,7036,1.05 [1.02-1.08],0.0027947613739559
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),50176,6424,1.08 [1.04-1.11],6.810738931972906e-06
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,51035,2432,1.05 [1.00-1.11],0.0653369252590316
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,51357,172,1.00 [0.81-1.22],0.9671292391687752
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,47429,1957,1.07 [1.01-1.13],0.0274221690968855
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,45820,2220,1.13 [1.07-1.20],7.626972471361279e-06
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,45559,516,1.10 [0.98-1.23],0.1038990990249944
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,36208,3985,1.09 [1.05-1.14],1.6618506900150187e-05
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,45253,788,1.19 [1.08-1.30],0.0002721215268445
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,51474,2871,1.05 [1.00-1.10],0.0697657912612304
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,Mycoses,51703,1018,1.01 [0.93-1.10],0.7797570485027968
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,50060,1861,1.01 [0.95-1.07],0.745577768452879
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,51565,2159,1.05 [0.99-1.11],0.106243067260762
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,49003,400,1.06 [0.93-1.21],0.3698878198495846
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,51803,100,1.11 [0.85-1.43],0.4471018315049687
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,51294,1888,1.05 [0.99-1.12],0.1060485357731835
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,51341,156,1.02 [0.82-1.26],0.8735546525903626
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,51640,317,0.98 [0.85-1.14],0.8277174739796893
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",51603,280,1.04 [0.89-1.22],0.6439424987576926
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,49043,844,1.10 [1.01-1.21],0.0331000541166169
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,48757,558,1.13 [1.01-1.26],0.0352444170699359
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,48826,223,1.05 [0.88-1.25],0.5899516691037827
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,51760,105,1.16 [0.91-1.49],0.2366534867915232
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,51671,309,1.05 [0.90-1.22],0.5380613777981889
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,Viral warts,51463,101,0.99 [0.76-1.29],0.9204647260590422
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],51494,132,1.09 [0.87-1.37],0.4667875018492942
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,Benign lipomatous neoplasm,51210,587,1.04 [0.93-1.16],0.4625771084019844
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,51626,116,0.95 [0.74-1.22],0.7022672436712836
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,51586,126,1.00 [0.79-1.26],0.973546689522698
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,23827,128,0.98 [0.77-1.23],0.8396321711940491
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",51135,2888,1.03 [0.98-1.08],0.2300867529496394
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,Benign neoplasm of meninges,51775,113,0.90 [0.70-1.16],0.4109475771951915
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,51670,129,0.94 [0.74-1.20],0.6388320174797947
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,51753,212,0.91 [0.76-1.10],0.3296469951890468
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,Benign neoplasm of ovary,27842,181,0.90 [0.73-1.10],0.3111925681507598
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,51756,730,1.04 [0.94-1.15],0.4166460652708627
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,Benign neoplasm: Caecum,51757,596,1.03 [0.93-1.15],0.5334696022449137
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",51582,147,0.89 [0.71-1.11],0.2848073142967197
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,Benign neoplasm: Descending colon,51752,434,0.96 [0.84-1.08],0.4794452463397569
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,Benign neoplasm: Rectum,51672,703,0.93 [0.84-1.03],0.1930485630806431
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,51570,1236,1.00 [0.92-1.07],0.9278683330451076
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,51740,865,1.03 [0.94-1.13],0.4780987767256608
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,Carcinoma in situ of breast,22629,138,0.78 [0.61-0.99],0.0431434631055535
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",22722,168,0.83 [0.67-1.03],0.0932439291285698
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",41243,103,0.83 [0.64-1.09],0.182929472954065
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",41279,139,0.86 [0.68-1.09],0.207095402159899
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",51704,236,1.04 [0.87-1.23],0.6831119579467662
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,"Haemangioma, any site",51705,231,1.05 [0.88-1.25],0.5993115607917379
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,Leiomyoma of uterus,26919,597,0.84 [0.75-0.95],0.0037377113469492
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,Lung cancer and mesothelioma,35908,664,0.85 [0.76-0.94],0.002049436064388
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,Lymphoid leukaemia,41243,103,0.89 [0.68-1.17],0.4156536292223931
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",41521,381,1.05 [0.92-1.21],0.4735660057689345
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",41547,407,1.10 [0.97-1.25],0.1558661245615955
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",22858,191,0.95 [0.78-1.15],0.6030337076103511
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",41298,158,1.23 [1.01-1.51],0.043401139603638
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",41355,215,1.17 [0.98-1.39],0.0859058315030655
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",41336,196,1.03 [0.86-1.24],0.7415693947588153
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",22812,145,1.14 [0.92-1.43],0.2357849690865532
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",41324,184,1.16 [0.96-1.41],0.1205142330003689
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",19875,1402,1.00 [0.93-1.07],0.9307491077802426
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",41369,229,0.87 [0.72-1.04],0.1147613092929335
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",41288,148,0.96 [0.77-1.20],0.7406095396178478
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,41351,211,1.01 [0.84-1.22],0.8996147301281303
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,Melanocytic naevi,51410,406,0.91 [0.80-1.04],0.1826788388986188
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,Melanocytic naevi of trunk,51724,175,0.89 [0.72-1.09],0.2668376922583142
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,Melanoma in situ,41209,164,0.98 [0.80-1.22],0.8858558940238644
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",41322,182,0.95 [0.77-1.15],0.5842887546189686
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",41463,323,1.04 [0.90-1.21],0.563142768150982
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",41590,450,0.91 [0.80-1.03],0.1209038608310033
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",41337,197,0.88 [0.72-1.07],0.1945070923650303
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,Other benign neoplasms of skin,51443,310,0.94 [0.80-1.09],0.3970689647605639
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",43306,2166,0.99 [0.94-1.05],0.8169721808326272
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",43424,2284,1.00 [0.95-1.06],0.9786685717656424
CPA2,Carboxypeptidase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,51215,689,0.93 [0.84-1.03],0.1628276599671457
CPA2,Carboxypeptidase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,48008,224,1.47 [1.24-1.73],5.479076897440767e-06
CPA2,Carboxypeptidase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,50670,144,1.48 [1.20-1.81],0.0001968072028776
CPA2,Carboxypeptidase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,50212,5822,1.10 [1.06-1.14],1.2851841109006617e-07
CPA2,Carboxypeptidase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,48856,97,0.99 [0.76-1.29],0.9277871962096488
CPA2,Carboxypeptidase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,50963,103,1.08 [0.83-1.39],0.5815036357520187
CPA2,Carboxypeptidase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,50830,3046,1.14 [1.09-1.19],8.603125273430522e-08
CPA2,Carboxypeptidase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,50828,3044,1.14 [1.08-1.19],1.103570342557691e-07
CPA2,Carboxypeptidase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,47960,176,1.19 [0.98-1.44],0.0860754835760322
CPA2,Carboxypeptidase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,51153,2394,1.15 [1.09-1.21],2.12093834271201e-07
CPA2,Carboxypeptidase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,51089,229,1.00 [0.84-1.19],0.9734086785782888
CPA2,Carboxypeptidase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,50654,128,0.86 [0.68-1.09],0.221100226551235
CPA2,Carboxypeptidase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,50645,119,0.97 [0.76-1.24],0.8160905139803041
CPA2,Carboxypeptidase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,51421,561,1.04 [0.93-1.16],0.4617755047549645
CPA2,Carboxypeptidase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,51591,112,1.33 [1.05-1.69],0.0178571158610921
CPA2,Carboxypeptidase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",51323,463,1.02 [0.91-1.16],0.7085158324272718
CPA2,Carboxypeptidase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,48968,209,1.21 [1.01-1.45],0.0343954268500062
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,40069,633,1.17 [1.06-1.30],0.0027256981092216
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,48311,232,0.85 [0.71-1.01],0.0652084118629572
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,48336,257,1.01 [0.85-1.19],0.940472976956928
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,39547,111,0.91 [0.70-1.18],0.4711968405939526
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,48117,136,1.18 [0.94-1.46],0.1493170708522732
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,46977,470,1.24 [1.10-1.39],0.0003547247376446
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",50852,1133,0.98 [0.91-1.06],0.6321726496756268
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,50250,531,1.09 [0.98-1.23],0.1221549595899833
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,49975,256,0.92 [0.78-1.09],0.3290255855174085
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,51096,3115,0.97 [0.93-1.02],0.2850411716818488
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,45140,3022,0.97 [0.93-1.02],0.2441397999699577
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",39571,135,1.31 [1.05-1.63],0.016681545378228
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",47759,160,0.95 [0.77-1.18],0.6623468217279189
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,39997,561,1.06 [0.94-1.18],0.3439937962258121
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,39555,119,0.88 [0.69-1.13],0.3276001395929481
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,46531,7095,1.09 [1.05-1.12],1.667936770552294e-07
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,39824,388,1.06 [0.93-1.22],0.3748358702382435
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,40544,1108,1.02 [0.94-1.10],0.6963973780550228
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,51637,653,1.04 [0.94-1.15],0.453550689454538
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,51259,275,1.32 [1.13-1.53],0.000379585843766
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,39688,252,0.89 [0.75-1.06],0.1863176767074153
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",39557,121,0.90 [0.70-1.16],0.4142904085565565
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,50711,3112,1.00 [0.96-1.05],0.8393495479332207
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,39956,520,1.22 [1.09-1.36],0.0005752466080545
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,40033,597,1.44 [1.30-1.59],1.6069576063631485e-12
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",40703,1267,1.09 [1.01-1.17],0.0288879773205156
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,39678,242,0.95 [0.80-1.13],0.5936927919120936
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,51242,258,1.27 [1.08-1.48],0.0035787636154839
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,40642,1206,1.00 [0.93-1.08],0.9454296029478338
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,40396,960,0.88 [0.80-0.96],0.0043264794269294
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,46644,137,1.54 [1.24-1.90],6.399061542922803e-05
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,49440,10004,1.06 [1.03-1.08],5.619338356004999e-05
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,47697,98,0.94 [0.72-1.24],0.672925106994026
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,47710,111,1.12 [0.87-1.45],0.373335210287723
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,51429,3897,1.02 [0.98-1.06],0.407565069030163
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",51431,3892,1.02 [0.98-1.06],0.4096214636111228
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,47704,105,1.11 [0.86-1.44],0.4245338862216237
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,51114,2419,1.00 [0.95-1.05],0.9568823061348598
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",42605,3169,1.05 [1.01-1.10],0.0290236882783124
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,51777,449,1.58 [1.41-1.76],1.063135919690647e-15
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,49887,168,1.10 [0.90-1.34],0.3681386746643403
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,48906,211,1.17 [0.98-1.39],0.0907207525074828
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,48980,285,1.01 [0.86-1.18],0.9107981286336472
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",39772,336,1.14 [0.98-1.32],0.0822075524666692
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,47143,309,1.91 [1.66-2.19],1.9738570881166284e-20
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,4251,171,1.37 [1.16-1.61],0.0001926721676259
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,4529,506,1.52 [1.38-1.67],8.247087928357923e-18
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,46961,127,2.06 [1.68-2.54],9.147716231610136e-12
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,4190,113,1.65 [1.35-2.03],1.1173075810487348e-06
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,50519,3685,1.34 [1.28-1.40],6.386048698437916e-42
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,50423,704,0.95 [0.86-1.05],0.2843466283932138
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,47236,729,1.13 [1.03-1.25],0.0113126634307126
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,40979,1543,1.10 [1.03-1.18],0.0054003519524022
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",51575,485,0.95 [0.85-1.08],0.4497299195729622
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),49542,322,0.88 [0.76-1.02],0.1025091205671245
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Angina pectoris,47320,2401,1.06 [1.00-1.12],0.0364822153136766
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,49696,476,0.93 [0.82-1.05],0.2243989806914319
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,49340,120,1.32 [1.06-1.65],0.014879694804761
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",49617,397,1.23 [1.08-1.39],0.0014938302591441
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,32148,3828,1.00 [0.96-1.05],0.8734357736919299
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,AV-block,43640,864,1.15 [1.05-1.25],0.0020803953901807
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",51686,849,0.96 [0.88-1.06],0.4290392134075189
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Cardiac arrest,28702,382,1.16 [1.01-1.32],0.0309272214997391
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,43111,335,0.93 [0.80-1.08],0.3372445555877646
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",42962,186,1.07 [0.88-1.30],0.4827160377699794
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,51800,100,1.24 [0.96-1.60],0.0931748571363114
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Conduction disorders,44878,2102,1.09 [1.03-1.16],0.0024561312826575
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,49048,4164,1.04 [1.00-1.09],0.046295528316374
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,45207,15160,1.02 [1.00-1.05],0.0395902943935068
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,49019,524,0.93 [0.83-1.04],0.2173983615723595
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Endocarditis,42922,146,1.21 [0.97-1.49],0.0870334144595526
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",51390,2207,1.07 [1.01-1.13],0.0242116090983337
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Hypertension,47049,13018,1.04 [1.01-1.06],0.0017891679741011
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",47085,13054,1.04 [1.01-1.06],0.0013550449623419
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",51458,156,1.40 [1.15-1.70],0.0007508940531533
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",34384,353,1.04 [0.90-1.20],0.5821377475555408
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,34303,272,1.65 [1.43-1.91],5.519874996890224e-12
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Hypotension,51513,2366,1.04 [0.98-1.09],0.2097474951176418
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,49954,216,0.95 [0.79-1.14],0.5469754289970825
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",49390,4471,1.04 [1.00-1.08],0.0675860228800276
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",51048,1122,1.03 [0.96-1.12],0.3969869804675209
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,43499,723,1.17 [1.06-1.29],0.0014529038131369
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,50838,1684,1.04 [0.97-1.10],0.2750657801944431
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",46342,1423,1.04 [0.97-1.12],0.2672729978890418
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",51617,312,1.13 [0.98-1.31],0.0928283901744412
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",51743,620,1.05 [0.95-1.17],0.3657874473136769
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Oesophageal varices,48605,110,1.41 [1.11-1.78],0.0042333351067608
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Other aneurysm,49374,154,1.03 [0.83-1.27],0.7906750541021798
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Other arrhythmias,43626,850,1.02 [0.94-1.12],0.6002874328235408
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,49422,202,1.26 [1.06-1.50],0.0101535214837658
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,49703,483,1.03 [0.91-1.16],0.6281159233361149
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,43134,358,0.93 [0.81-1.07],0.3153140088682457
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Other disorders of veins,48691,196,0.94 [0.78-1.14],0.5365821068354385
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,48590,95,0.86 [0.65-1.14],0.3051901430301601
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,48935,131,0.97 [0.77-1.22],0.7827237728690524
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,48772,277,1.10 [0.94-1.28],0.2365056929280447
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,44854,2078,1.02 [0.96-1.08],0.5996090827344475
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,49257,110,1.31 [1.04-1.66],0.0241383673864117
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,50303,1083,1.07 [0.99-1.16],0.1071683488117303
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,50566,691,1.01 [0.92-1.12],0.7981109133027308
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",50031,1227,1.02 [0.94-1.10],0.674837819761539
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,28991,671,1.06 [0.96-1.18],0.2360610088100705
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,49962,805,1.14 [1.04-1.24],0.0045067864994544
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),49182,687,0.97 [0.88-1.07],0.5608624405146527
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,50830,955,1.03 [0.94-1.12],0.5553595590027205
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,51659,1317,1.04 [0.97-1.12],0.2676457337878646
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,43472,696,1.00 [0.91-1.11],0.927701822001586
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,50555,680,1.02 [0.92-1.12],0.718037573019128
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,49191,387,1.02 [0.89-1.16],0.7706977199746854
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",51025,1287,1.03 [0.96-1.11],0.4506302745763907
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",50984,1365,1.02 [0.95-1.09],0.6201323373742214
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,49897,120,0.81 [0.63-1.04],0.0998364858635307
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,49382,163,0.94 [0.77-1.16],0.5909974095661038
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,50400,474,0.98 [0.86-1.10],0.7102115774220452
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,49674,520,1.03 [0.91-1.15],0.6622827469410633
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Varicose veins,49343,848,1.03 [0.94-1.13],0.4904561341646065
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,49247,170,0.83 [0.67-1.02],0.0808500426659682
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,51347,1502,0.99 [0.93-1.06],0.8775064651890258
CPA2,Carboxypeptidase A2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",51559,715,0.96 [0.87-1.06],0.4277010327139664
CPA2,Carboxypeptidase A2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",45330,2855,1.00 [0.95-1.05],0.9119542667741538
CPA2,Carboxypeptidase A2,Chapter V Mental and behavioural disorders,Any mental disorder,50494,8019,1.00 [0.97-1.03],0.8955269016706382
CPA2,Carboxypeptidase A2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",51464,846,0.94 [0.86-1.03],0.1624015594072186
CPA2,Carboxypeptidase A2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",45649,3174,0.98 [0.93-1.02],0.3329911652831987
CPA2,Carboxypeptidase A2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",42654,179,1.00 [0.82-1.22],0.9663348483937574
CPA2,Carboxypeptidase A2,Chapter V Mental and behavioural disorders,Smoking dependency,50732,2745,1.03 [0.98-1.08],0.302597526876407
CPA2,Carboxypeptidase A2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",45743,3268,1.01 [0.97-1.06],0.5983342782905859
CPA2,Carboxypeptidase A2,Chapter V Mental and behavioural disorders,Vascular dementia,50779,254,1.14 [0.97-1.34],0.1111572932100722
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Alzheimer disease,51802,661,1.12 [1.01-1.24],0.0329209759678195
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",34933,118,0.88 [0.69-1.14],0.3326334831737911
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Bell's palsy,48235,159,1.00 [0.81-1.23],0.980871293332502
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,49065,989,1.02 [0.94-1.11],0.5842248711859599
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Cerebral cysts,50979,460,1.00 [0.88-1.13],0.9796586773615024
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,51642,650,0.98 [0.88-1.09],0.7002771415806168
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,50796,99,1.07 [0.82-1.39],0.6302250042916568
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,51768,120,0.96 [0.76-1.22],0.750673773195212
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",50668,149,1.04 [0.84-1.30],0.7023825255117973
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Epilepsy,48667,575,0.96 [0.86-1.08],0.497941403519512
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,50840,2748,1.02 [0.97-1.07],0.5515580604425238
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,51719,1210,0.96 [0.89-1.04],0.3363728022736957
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,50605,5167,1.04 [1.00-1.08],0.0394611303006591
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Generalized epilepsy,51033,107,0.90 [0.70-1.17],0.4476041622745992
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Hemiplegia,51499,507,0.98 [0.88-1.11],0.7894969393304068
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Hydrocephalus,50643,124,0.99 [0.78-1.26],0.9329173255305084
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,51765,140,1.05 [0.84-1.31],0.6947694190817255
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,48224,148,0.95 [0.76-1.19],0.6603424902735828
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,48237,161,0.95 [0.77-1.17],0.6247944721925254
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Memory loss,50488,219,1.02 [0.85-1.22],0.834899880031009
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Migraine,48811,719,1.05 [0.95-1.16],0.3783688627490609
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",51662,647,1.04 [0.93-1.15],0.5121301496620765
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Motor neuron disease,35130,275,0.87 [0.74-1.03],0.0984891656898078
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,51464,209,0.91 [0.76-1.10],0.3505235578007118
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",50471,2395,1.01 [0.96-1.07],0.6733185653936764
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Neurological diseases,48839,7554,1.01 [0.98-1.04],0.5404835428386583
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,51103,406,1.02 [0.89-1.16],0.7812658666894021
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",48898,822,1.00 [0.91-1.10],0.9964860670655288
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",51649,591,1.22 [1.09-1.35],0.0002472581091484
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,41214,1300,1.04 [0.97-1.12],0.2943901245203179
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,50667,148,1.02 [0.82-1.27],0.8253690048229216
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,50801,282,1.22 [1.05-1.42],0.0100804413295073
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,50837,328,0.91 [0.79-1.06],0.2304823552324034
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,48265,189,1.00 [0.83-1.21],0.9809405956658096
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Other headache syndromes,48206,114,0.92 [0.71-1.18],0.5036218907766816
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Other neurological diseases,51559,1040,1.05 [0.97-1.14],0.2012028332314536
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Other sleep disorders,49211,1119,1.03 [0.95-1.11],0.5062972117422364
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Parkinson's disease,51756,855,0.99 [0.90-1.08],0.7495379470439941
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,50630,111,1.04 [0.81-1.35],0.743182859925709
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Restless leg syndrome,51801,156,0.84 [0.68-1.05],0.1178547849102179
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Sleep apnoea,51318,962,1.02 [0.94-1.11],0.6482086813183761
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,51157,99,0.89 [0.67-1.16],0.3829492394345097
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,51774,329,0.86 [0.74-1.00],0.0534499482000049
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,48179,103,0.83 [0.63-1.09],0.1771695934760885
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,51802,668,1.11 [1.01-1.23],0.0387446783540802
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),50704,247,1.15 [0.98-1.36],0.094459900204
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,50658,197,0.87 [0.72-1.06],0.1580868751468384
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,50977,799,1.01 [0.92-1.11],0.7839336537862212
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,51455,468,2.06 [1.86-2.28],3.812527675689895e-43
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,49789,106,0.79 [0.61-1.04],0.0887806914196541
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,49799,116,0.77 [0.59-0.99],0.0447155347595465
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",51583,104,0.97 [0.75-1.25],0.8022549082271945
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,51275,294,1.05 [0.90-1.22],0.5586529733109147
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",4201,121,1.54 [1.26-1.87],1.6472277031177536e-05
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,5087,202,1.19 [1.02-1.39],0.0290104405871918
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,50650,189,1.00 [0.82-1.21],0.9725975903733476
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,51369,2075,1.20 [1.13-1.26],7.29256679267548e-10
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",51067,1384,0.95 [0.88-1.02],0.1487143480516682
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,50130,447,0.89 [0.79-1.02],0.0894300433778255
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",51632,1454,1.00 [0.93-1.07],0.9554045604514216
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,51783,138,1.07 [0.85-1.34],0.5631226734765258
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,51483,1305,1.02 [0.94-1.09],0.6588421599770427
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",51714,733,1.14 [1.03-1.25],0.0087707964972813
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,51614,359,0.90 [0.78-1.04],0.142339374918884
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,49800,117,1.09 [0.85-1.38],0.4945547750601701
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,49818,135,0.89 [0.70-1.12],0.3107299359029419
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,49794,111,0.77 [0.59-1.00],0.0498288066757487
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,51614,1408,1.04 [0.97-1.12],0.2430566655332893
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,50572,366,0.93 [0.81-1.07],0.2981352255655505
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,50275,97,0.82 [0.62-1.09],0.1732659131468999
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,51180,199,1.09 [0.90-1.31],0.3898670974982189
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,51531,550,1.14 [1.02-1.28],0.0203057472844171
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,50568,390,1.05 [0.92-1.20],0.4572676878148307
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,51475,220,0.94 [0.79-1.13],0.5361251175769387
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,51145,939,1.06 [0.97-1.15],0.1853925817726421
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,50741,280,1.04 [0.89-1.22],0.5902562270165118
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,48592,4368,1.05 [1.01-1.10],0.012056175395464
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,51458,477,1.15 [1.02-1.29],0.0244213875279465
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,51761,307,1.06 [0.92-1.24],0.4159849129858985
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,50501,818,0.95 [0.86-1.04],0.2659275471426647
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,51109,128,1.25 [1.00-1.57],0.0499199213156053
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,51757,112,1.21 [0.95-1.54],0.1289373099611994
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,49854,171,0.97 [0.79-1.19],0.7932096398714745
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,49980,297,0.98 [0.84-1.15],0.8172230089970276
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,49531,237,1.21 [1.02-1.43],0.0264791644321502
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,50301,123,0.85 [0.66-1.09],0.1979668892585318
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",49421,127,0.81 [0.63-1.03],0.0870556347904589
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,50381,175,0.89 [0.72-1.10],0.2700028576091903
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",50595,389,1.07 [0.94-1.23],0.3009345333065658
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,49937,254,1.03 [0.87-1.21],0.7520142025161632
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,49515,221,1.10 [0.92-1.32],0.2964966736611742
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,49465,171,1.25 [1.03-1.52],0.0250461080002299
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,47842,3618,1.04 [0.99-1.08],0.1192432078716201
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,49828,145,0.91 [0.72-1.14],0.3950237709768036
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,51283,822,0.96 [0.88-1.06],0.4464997732851831
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,50579,118,0.98 [0.77-1.25],0.8855165590369067
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),50803,342,1.03 [0.89-1.18],0.7202697376737561
CPA2,Carboxypeptidase A2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,51377,177,1.12 [0.92-1.37],0.2477128281652604
CPA2,Carboxypeptidase A2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,51713,240,0.95 [0.80-1.13],0.5805089016772571
CPA2,Carboxypeptidase A2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,51537,263,1.11 [0.94-1.30],0.2245348586938175
CPA2,Carboxypeptidase A2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,51320,120,1.05 [0.82-1.34],0.6995575598745833
CPA2,Carboxypeptidase A2,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,51326,126,1.17 [0.93-1.47],0.181656072287354
CPA2,Carboxypeptidase A2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,51607,1802,0.99 [0.93-1.06],0.8686558652614924
CPA2,Carboxypeptidase A2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,51092,1287,1.00 [0.93-1.08],0.9536308922202106
CPA2,Carboxypeptidase A2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,50059,254,1.03 [0.88-1.22],0.7011724900509677
CPA2,Carboxypeptidase A2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,49978,173,0.93 [0.76-1.14],0.4993441488410939
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Acute pharyngitis,51313,148,0.97 [0.78-1.20],0.7616632268839779
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,51592,427,1.04 [0.92-1.18],0.5242993109020925
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,51294,129,1.09 [0.87-1.37],0.4567161233551481
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,All influenza,47736,237,1.17 [0.99-1.38],0.0660625445872918
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),47731,232,1.16 [0.98-1.38],0.0861208440338225
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),35478,234,1.07 [0.90-1.27],0.4710442185157509
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Allergic rhinitis,51539,559,0.96 [0.85-1.07],0.4379168714403424
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",38252,3550,1.02 [0.97-1.06],0.4948896545491049
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",38742,3498,1.02 [0.97-1.07],0.3964680686829596
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),50984,280,0.85 [0.72-1.00],0.0454527864748485
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",47664,165,0.82 [0.66-1.01],0.0586329133851153
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Bronchiectasis,44908,715,0.92 [0.83-1.01],0.0888970311689662
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",44310,117,0.98 [0.76-1.25],0.8490994079578645
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,49777,5584,0.99 [0.96-1.03],0.6818520814452386
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",49050,140,0.81 [0.64-1.02],0.0732525337169177
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Chronic sinusitis,49219,309,1.02 [0.87-1.18],0.8428715312366328
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",51399,2385,0.98 [0.93-1.03],0.4015961045065587
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Deviated nasal septum,49120,210,0.99 [0.83-1.19],0.9384388815317602
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,47661,10553,1.01 [0.98-1.03],0.5955111385350296
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",49638,728,1.03 [0.93-1.13],0.6077836112972459
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Early onset COPD,49643,629,1.05 [0.95-1.17],0.314202264430468
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Emphysema,44816,623,0.93 [0.83-1.03],0.1694880876850016
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,49200,571,0.90 [0.81-1.01],0.0728802746044848
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,51352,3853,1.01 [0.97-1.06],0.5730320512102014
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Interstitial lung disease,49269,640,0.92 [0.83-1.02],0.1265135102515564
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Later onset COPD,49796,1756,0.96 [0.90-1.02],0.1900690212671487
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,51776,659,0.99 [0.89-1.10],0.846604951617381
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Nasal polyp,49125,215,1.06 [0.88-1.27],0.5392859093787052
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,51303,1947,1.03 [0.97-1.09],0.3162902214174873
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Other diseases of pleura,51329,3994,0.98 [0.94-1.03],0.4242677700355586
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,50578,1668,0.99 [0.93-1.06],0.8179079620290528
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Other pleural conditions,47438,103,1.01 [0.78-1.31],0.9389635855944451
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,51623,800,0.93 [0.85-1.02],0.1422822361933547
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,51587,2599,0.99 [0.94-1.05],0.842568265938182
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Pleural effusion,49330,1995,0.98 [0.93-1.04],0.5890529304113952
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Pleural plaque,47646,311,0.85 [0.73-0.99],0.0360893717658192
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",50847,3348,1.01 [0.97-1.06],0.6244081894405813
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,51647,530,1.02 [0.91-1.14],0.7874677179195513
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Pneumothorax,47569,234,0.96 [0.80-1.14],0.6141489215238389
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Pollen allergy,51754,477,0.96 [0.85-1.09],0.5539650119431963
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Pulmonary oedema,50954,131,1.06 [0.85-1.33],0.5881788748587544
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,35352,108,0.59 [0.45-0.78],0.0001674272166359
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,51259,1903,1.03 [0.97-1.10],0.2762884385596854
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,49471,561,0.96 [0.86-1.07],0.4697036952120641
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Viral pneumonia,47999,500,1.12 [0.99-1.25],0.0621496160390913
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",51013,412,1.09 [0.96-1.23],0.1940995136982201
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,23884,224,1.10 [0.92-1.32],0.2789572283797767
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,36602,130,1.08 [0.86-1.36],0.4924813403444349
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Acute appendicitis,51481,290,1.11 [0.95-1.29],0.2083051694770849
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Acute gastritis,38974,180,0.96 [0.78-1.17],0.6678283788053101
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Acute pancreatitis,48105,367,1.10 [0.96-1.26],0.1811755929544532
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Acute peritonitis,50851,189,1.23 [1.03-1.49],0.0260369166695653
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,50012,150,1.05 [0.85-1.30],0.6350344816019744
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Barrett oesophagus,39665,871,1.00 [0.91-1.09],0.94909907978304
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",47938,200,1.15 [0.96-1.38],0.1249992278171879
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",50960,200,1.15 [0.96-1.38],0.1177469122833053
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Cholecystitis,48149,411,0.94 [0.82-1.07],0.3452917228550725
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Cholelithiasis,49724,1986,0.96 [0.91-1.02],0.2205289124039315
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Chronic gastritis,39402,608,1.05 [0.94-1.17],0.3938760357016406
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,47837,99,0.94 [0.72-1.23],0.6364794288791032
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",51511,209,1.18 [0.99-1.40],0.0633831944263321
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Coeliac disease,48579,250,4.60 [4.08-5.18],1.0143466224476076e-139
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Collagenous colitis,48431,165,1.06 [0.86-1.30],0.5851682315251736
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,51498,374,0.98 [0.85-1.12],0.722155975311621
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Constipation,51285,3355,0.96 [0.92-1.01],0.1049953468572264
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Crohn disease,48451,185,1.37 [1.14-1.65],0.0007924347190045
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",51093,136,1.31 [1.06-1.63],0.0133630302690769
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,48441,175,1.34 [1.11-1.62],0.0026262382316246
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Dental caries,50310,458,0.94 [0.83-1.07],0.3698259043055653
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,46490,4467,1.04 [1.00-1.09],0.0325594735949487
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Diseases of appendix,51556,365,1.08 [0.94-1.24],0.2901270706242642
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Diseases of liver,51558,1696,1.11 [1.04-1.18],0.0015277546112042
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",47465,8671,1.05 [1.02-1.08],0.0004701883835177
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",50959,1107,1.00 [0.92-1.08],0.998364184041744
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,51624,962,1.01 [0.92-1.10],0.8748851083957057
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,50081,229,0.82 [0.69-0.99],0.0355999930955737
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,49784,129,0.97 [0.76-1.22],0.7701988202033037
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,51172,2843,1.16 [1.10-1.21],6.7811024618707276e-09
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Diseases of tongue,49817,222,0.94 [0.78-1.12],0.4703114025220297
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",50545,2807,1.00 [0.95-1.05],0.9907358732577146
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,42799,6327,0.99 [0.96-1.02],0.5511321801375875
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Duodenal ulcer,39194,400,1.16 [1.02-1.32],0.0242741206957491
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",51634,322,1.08 [0.93-1.24],0.3107099934922054
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,51621,112,0.86 [0.66-1.12],0.2683213319321061
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,50115,253,1.27 [1.09-1.49],0.0025861105246993
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,36767,295,0.97 [0.83-1.14],0.7420518334009418
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Functional dyspepsia,39892,1098,0.97 [0.90-1.06],0.5374617847946322
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Gastric ulcer,39513,719,1.06 [0.96-1.17],0.2136641346798492
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,43804,5010,1.02 [0.98-1.06],0.3891876112914455
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,39870,1076,1.08 [0.99-1.16],0.0735622067917131
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,40101,16618,1.02 [1.00-1.04],0.062417310066524
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,GI-bleeding,50655,2326,0.97 [0.92-1.02],0.2577874852157343
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,49957,105,0.89 [0.68-1.15],0.3687462496387536
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,38424,2513,0.99 [0.93-1.04],0.6196293270889379
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",49987,125,1.12 [0.89-1.41],0.3261196073820021
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Hernia,48531,6508,1.02 [0.99-1.06],0.1719678328290954
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Impacted teeth,51635,104,0.86 [0.66-1.13],0.288976773430771
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Impaction of intestines,36585,113,1.26 [0.99-1.60],0.0620817808898494
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Inguinal hernia,43832,1809,0.98 [0.92-1.04],0.5095768349935547
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",42230,207,0.96 [0.79-1.15],0.633941461741995
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,36665,193,0.88 [0.73-1.08],0.2162470007057708
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,48619,290,4.07 [3.63-4.56],2.864435489612884e-130
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,37583,1111,0.94 [0.87-1.03],0.1710508566439861
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,51745,741,1.17 [1.07-1.28],0.000999002653006
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,49782,1516,1.05 [0.98-1.12],0.1690204445304614
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,50283,2017,1.05 [0.99-1.11],0.1055428277186051
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,39172,378,1.08 [0.94-1.23],0.2757576638808441
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Oesophagitis,40001,1207,1.13 [1.05-1.22],0.0011696882888578
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,51702,272,1.14 [0.97-1.34],0.1060085244062283
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,42160,137,0.94 [0.75-1.18],0.6012698825033946
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,39190,2718,1.03 [0.98-1.09],0.206048242214737
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,48298,560,1.07 [0.96-1.20],0.2155988754451683
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,48055,317,0.86 [0.74-1.00],0.0532753287874849
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Other diseases of intestine,39958,3486,1.05 [1.01-1.10],0.0231747248369051
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Other diseases of intestines,47785,11313,1.00 [0.97-1.02],0.9240959671708212
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,49767,410,1.07 [0.94-1.22],0.3135288646493582
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Other diseases of liver,51251,1389,1.14 [1.06-1.22],0.0001807570922535
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,40124,1330,0.99 [0.92-1.06],0.6936631122524213
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,48040,302,1.16 [1.00-1.35],0.0484628250395548
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,51486,824,0.96 [0.87-1.05],0.3872955405989157
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,40700,1906,1.09 [1.02-1.16],0.0068532142877657
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,50686,2357,0.97 [0.92-1.03],0.317783708655054
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,50227,375,1.02 [0.89-1.16],0.8177110935982675
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,39922,3450,0.96 [0.92-1.01],0.1013021383073698
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),42827,4033,1.08 [1.03-1.12],0.0004579371479843
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,50062,200,1.32 [1.10-1.57],0.0022641858696018
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,50037,1771,1.04 [0.97-1.10],0.2723613540833787
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",37162,690,0.97 [0.88-1.08],0.5741052747433846
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,51601,132,0.90 [0.71-1.15],0.3984686185300191
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,37452,980,0.97 [0.89-1.06],0.486236699131675
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",48628,299,1.00 [0.85-1.16],0.9671278890921564
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,51779,112,1.03 [0.80-1.32],0.8341894946418548
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,49860,235,1.05 [0.89-1.25],0.5489994646782096
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Toxic colitis,48379,113,0.90 [0.70-1.17],0.4397353767547627
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,39330,536,0.97 [0.87-1.09],0.6180903279047211
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Ulcerative colitis,48585,319,0.98 [0.85-1.14],0.8206017876271854
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",48532,266,0.91 [0.77-1.07],0.2462504173848665
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Umbilical hernia,42570,547,1.04 [0.93-1.16],0.5210994040212383
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,36820,348,0.89 [0.77-1.03],0.1148942917695614
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Ventral hernia,42545,522,0.99 [0.88-1.11],0.8402176649477001
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Volvulus,36630,158,0.90 [0.73-1.12],0.3627989798317972
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,51640,598,1.00 [0.89-1.11],0.9535673160707596
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,51154,144,1.04 [0.83-1.29],0.7454579818431488
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,47687,322,0.96 [0.83-1.12],0.6338003062216607
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,50526,1409,1.05 [0.98-1.13],0.1454839478400913
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",49466,349,1.14 [1.00-1.31],0.0573929391708165
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,48187,822,1.15 [1.05-1.26],0.0017069696891642
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,51188,556,1.05 [0.94-1.18],0.3815391476337033
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,51598,966,1.04 [0.96-1.14],0.3279638321624434
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,50729,97,0.97 [0.74-1.27],0.8138079157017951
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,48679,6427,1.02 [0.99-1.06],0.1520709923431587
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,50895,899,0.98 [0.89-1.07],0.6203387017741748
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,50630,634,1.01 [0.91-1.13],0.786370020258371
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,51015,1898,1.05 [0.99-1.12],0.0897093489162198
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",51769,109,0.81 [0.62-1.06],0.123804042772643
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,47479,114,0.86 [0.66-1.11],0.2458716377025463
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,50102,106,0.83 [0.64-1.07],0.1549977291665428
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,51167,535,1.05 [0.94-1.18],0.3907614823994274
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,48276,911,0.99 [0.91-1.09],0.8900458026997365
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,47495,130,1.11 [0.89-1.40],0.357709904387938
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,51628,167,0.92 [0.75-1.13],0.4377176159194812
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,49496,379,1.20 [1.06-1.37],0.0056634291239451
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,51397,387,1.09 [0.96-1.24],0.1996261417683464
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,50761,129,1.01 [0.81-1.27],0.917472492843731
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,47499,134,1.07 [0.85-1.34],0.5762011177016833
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,50641,3276,1.05 [1.00-1.10],0.0505153997958959
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",48353,988,1.00 [0.92-1.09],0.9388791152032012
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,47503,138,1.11 [0.89-1.39],0.3456200335632552
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,51622,612,1.03 [0.92-1.14],0.6186461980375022
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,50771,139,0.91 [0.72-1.14],0.3933343101539688
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,51511,501,1.08 [0.96-1.21],0.2135039061725581
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,51694,652,0.98 [0.89-1.09],0.7607644950289696
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,47618,253,0.90 [0.76-1.07],0.2326554967606448
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,47902,537,0.98 [0.87-1.10],0.702958380289637
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,51674,632,0.98 [0.88-1.09],0.7534791315090968
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",47844,479,1.13 [1.01-1.27],0.0315423777897017
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,51741,280,0.86 [0.73-1.01],0.0687104003481258
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,44426,221,1.02 [0.85-1.22],0.8357576071081446
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,47131,11290,1.01 [0.99-1.04],0.2560031455094169
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,44307,8466,1.01 [0.98-1.04],0.6779294667771327
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,44357,152,1.07 [0.86-1.32],0.5576317682891564
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,44915,308,1.09 [0.94-1.26],0.2669982272040624
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,44962,355,0.98 [0.85-1.14],0.8342119170730977
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,51305,185,1.29 [1.07-1.56],0.0068953616353797
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",44806,199,0.96 [0.79-1.16],0.6737759101662412
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,38108,2267,0.99 [0.94-1.05],0.7320054810104654
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",51529,379,1.05 [0.91-1.20],0.5221045373700437
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,45499,892,0.93 [0.85-1.02],0.111926507066953
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,43763,14522,1.00 [0.98-1.02],0.8420887775294243
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,47828,233,0.99 [0.83-1.17],0.8682966017689557
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,44509,304,0.95 [0.81-1.10],0.4849596817481538
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,45348,1143,0.96 [0.89-1.05],0.3814919513755854
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,49934,5327,0.98 [0.94-1.02],0.2797340793939435
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,44753,548,0.95 [0.85-1.07],0.4015035317952594
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,44644,439,0.93 [0.82-1.06],0.280455694873673
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,44475,270,0.93 [0.79-1.10],0.4141995909580591
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,50510,140,0.85 [0.67-1.07],0.1569030201240362
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,39226,3385,1.00 [0.95-1.04],0.8631649136982474
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,37050,1209,1.19 [1.11-1.28],3.3665882008234783e-06
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",51648,1192,1.19 [1.11-1.28],3.182835136297403e-06
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,35993,152,0.94 [0.75-1.17],0.5663730385480155
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),36504,663,0.97 [0.87-1.08],0.5929312590570699
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,44814,609,1.02 [0.92-1.14],0.6945579686095796
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,37119,1278,1.01 [0.94-1.09],0.8273140471857849
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,44719,112,1.08 [0.84-1.39],0.5411387281096256
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,45867,1260,1.00 [0.93-1.08],0.9349893251840556
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,45216,609,0.93 [0.83-1.03],0.16969373539811
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,37034,1193,1.01 [0.94-1.09],0.7619758150365548
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,44367,162,1.06 [0.86-1.31],0.5786734873427681
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",44329,124,0.81 [0.63-1.03],0.0905339534235711
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,47741,146,1.05 [0.85-1.30],0.6678238676454415
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,51024,3429,1.03 [0.98-1.08],0.1896480288210164
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,49836,2241,1.03 [0.97-1.09],0.2809467310000741
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",51520,904,1.02 [0.94-1.12],0.5986228129081068
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,40830,4989,0.99 [0.95-1.03],0.5993875229691998
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,35966,125,0.90 [0.71-1.15],0.4169965750335359
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,44390,185,0.82 [0.67-1.00],0.049899895668645
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,35938,97,1.06 [0.81-1.38],0.6845775513342793
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),36093,252,0.87 [0.73-1.04],0.1304520274003842
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,48079,484,1.09 [0.97-1.23],0.1373718802145822
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,48358,763,0.95 [0.86-1.05],0.3293810740929895
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,51736,201,0.95 [0.79-1.15],0.6048330059497654
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",48218,3611,1.00 [0.96-1.05],0.9601061755963662
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,44407,202,0.87 [0.72-1.06],0.1739582166534906
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),36120,279,1.00 [0.85-1.18],0.9882294928116552
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,46063,1456,0.96 [0.90-1.03],0.2636580823787479
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,40155,4314,0.98 [0.94-1.02],0.3584153180883985
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,50559,189,0.84 [0.69-1.03],0.0931291564099902
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,51763,138,1.05 [0.84-1.31],0.6644640011700245
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,44369,164,1.04 [0.84-1.28],0.7186956661319924
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",46713,2508,0.94 [0.89-1.00],0.0330199403612252
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,44385,180,0.92 [0.75-1.13],0.4199426083308353
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,39072,3231,0.99 [0.94-1.04],0.6534097434202126
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,47819,224,0.97 [0.81-1.16],0.748095915922466
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,44313,108,0.94 [0.73-1.23],0.6622487675743247
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,44926,319,0.96 [0.82-1.11],0.568689771051504
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,45312,1107,0.96 [0.89-1.04],0.325937459000633
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,51083,713,0.89 [0.81-0.99],0.0311403078985356
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,45750,1143,1.03 [0.96-1.12],0.4072486079372472
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,51544,878,1.02 [0.93-1.11],0.7344119505971661
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,51758,108,1.04 [0.80-1.34],0.788003636553724
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,44588,383,1.00 [0.87-1.15],0.970840323341034
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,41001,1514,0.97 [0.91-1.04],0.4496623090834265
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,45378,1173,0.96 [0.88-1.03],0.2573219243143876
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],44664,459,0.94 [0.83-1.07],0.3615181315785017
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",35949,108,1.01 [0.78-1.31],0.9516186439924628
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,40803,4962,1.04 [1.00-1.07],0.0708297097829003
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,37150,1309,1.01 [0.93-1.08],0.866908289303649
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,50836,466,0.89 [0.78-1.01],0.0672442748780322
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",51668,133,0.97 [0.77-1.22],0.7960849694881638
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",47454,102,1.09 [0.85-1.40],0.5118304490863683
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,35982,141,1.05 [0.84-1.31],0.6752762787089264
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,44810,203,0.97 [0.81-1.17],0.7713124944986488
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,36757,916,1.03 [0.95-1.13],0.4505357418278208
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,44824,619,1.14 [1.02-1.26],0.0157157632316769
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,45115,508,1.02 [0.90-1.14],0.8033735821487522
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,44983,376,0.97 [0.84-1.12],0.6829149440343569
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,40514,114,1.10 [0.86-1.41],0.44816451926026
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",51766,116,1.12 [0.88-1.43],0.3457736824546162
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,45392,1187,1.03 [0.95-1.11],0.5177732958998383
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],50558,188,1.02 [0.84-1.24],0.8587684157403547
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,49373,5168,0.96 [0.92-0.99],0.0198622189588676
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",44467,262,1.00 [0.85-1.19],0.9587421834126052
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,45690,1083,0.96 [0.89-1.05],0.3789465990311805
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,48979,469,0.94 [0.83-1.06],0.315745019344358
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,45021,414,0.95 [0.83-1.08],0.4224979312760188
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,47722,3115,0.97 [0.93-1.02],0.2488678743359179
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,46652,2045,0.98 [0.92-1.04],0.4834550986753455
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],44314,109,0.82 [0.63-1.07],0.1418383079008016
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,50638,268,0.93 [0.79-1.10],0.4022124627041683
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,44533,328,1.04 [0.90-1.21],0.5900134969130171
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,44356,151,1.15 [0.93-1.42],0.2059032414059778
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),35958,117,0.72 [0.55-0.93],0.0111904300845014
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,49693,3157,1.21 [1.16-1.27],1.643280169947364e-16
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),20903,102,0.85 [0.65-1.12],0.2491326640241624
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,27216,111,0.96 [0.74-1.25],0.7844409940959386
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,51162,650,1.07 [0.97-1.19],0.1910102550680976
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,50681,169,1.11 [0.91-1.35],0.3163496843915603
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,49608,3072,1.36 [1.30-1.42],2.452023379029828e-40
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,51372,165,1.55 [1.29-1.87],3.9259433161122505e-06
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,51308,601,1.12 [1.01-1.25],0.0298747065669217
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Cystitis,45619,465,0.95 [0.84-1.07],0.3989930081187809
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Dialysis,46691,155,2.34 [1.96-2.79],5.912917302797184e-21
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,22593,3332,0.98 [0.93-1.02],0.3546030927105851
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,27449,344,1.05 [0.90-1.21],0.5551213857804065
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Endometriosis,20984,183,0.82 [0.67-1.01],0.0655211554827631
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",21200,399,0.79 [0.69-0.91],0.0008988887425094
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21823,1022,0.98 [0.90-1.06],0.596131263563421
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,43244,10760,1.02 [0.99-1.05],0.1155901080223441
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,51374,167,1.85 [1.55-2.21],9.38655737114676e-12
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Hydrocele,19469,208,0.98 [0.82-1.18],0.8399496309487003
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,46524,588,1.10 [0.99-1.23],0.0878512950789077
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,21878,2617,0.98 [0.93-1.03],0.4400556896637833
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,27365,407,0.85 [0.74-0.98],0.0239534135424479
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),19495,234,0.94 [0.79-1.12],0.5167846954812065
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Irregular menses,27456,129,0.76 [0.60-0.98],0.0340020688656953
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,21109,308,0.81 [0.69-0.95],0.0086913766531606
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,45314,160,0.81 [0.65-1.01],0.0596192942116488
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,23299,2498,0.93 [0.88-0.98],0.0068113044248078
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,19369,108,0.98 [0.76-1.26],0.8773525579035559
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,20946,145,0.93 [0.74-1.17],0.5368529925739423
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",51775,127,1.00 [0.79-1.26],0.9726847827250252
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",51785,132,0.91 [0.72-1.15],0.4460421522179453
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,49688,4534,1.00 [0.96-1.04],0.8498896825984896
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,46594,1440,0.94 [0.88-1.01],0.1158128799213558
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,27225,120,1.07 [0.83-1.37],0.6092486756523365
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,51664,957,1.16 [1.07-1.26],0.0005122562971068
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,19571,310,1.11 [0.96-1.29],0.1563973855805341
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,19542,281,0.95 [0.82-1.12],0.5609307957458413
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,19496,235,0.93 [0.78-1.10],0.381232130123081
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,51725,137,1.16 [0.93-1.45],0.2005217385686648
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,48653,3499,1.02 [0.98-1.07],0.3182133877304007
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,27169,211,0.80 [0.66-0.96],0.0197693753865104
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,20959,158,0.93 [0.75-1.16],0.5318555167826062
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",21180,379,0.85 [0.74-0.98],0.0228035906012693
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,20917,116,0.92 [0.71-1.19],0.5332709809523324
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,21009,208,0.95 [0.79-1.15],0.5968536942708479
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,46620,684,1.09 [0.99-1.21],0.0788386386623682
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,51026,319,1.22 [1.06-1.40],0.0068322216775992
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,21118,317,0.83 [0.71-0.97],0.0200651426749276
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,20909,108,1.04 [0.80-1.35],0.7683398718959441
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,21459,658,0.89 [0.80-0.99],0.0291160987161209
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,20963,162,1.25 [1.02-1.54],0.0344888043299799
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,21401,600,0.95 [0.85-1.06],0.353289583845025
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,51305,98,1.47 [1.14-1.89],0.0025817041420315
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",19527,266,1.00 [0.85-1.18],0.9736755150116873
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,51298,5362,1.19 [1.15-1.23],3.1545675163471574e-22
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",46173,237,1.06 [0.89-1.27],0.4784312633537224
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,46796,260,1.25 [1.06-1.46],0.0062747433122614
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,50626,114,0.98 [0.76-1.25],0.8546745484558809
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,45594,440,0.92 [0.81-1.05],0.2148961496476841
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,51314,802,1.06 [0.97-1.17],0.1981016130032321
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,20944,143,0.77 [0.61-0.97],0.0276191053730623
